Blood Irradiation Market to Reach USD 104.37 Million by 2028, Growing at a CAGR of 7.0%

The Global Blood Irradiation Market is on a solid growth trajectory, and a new market research report by The Insight Partners offers a detailed look at where the industry stands and where it is headed. According to the The Insight Partners, the blood irradiation market is projected to reach USD 104.37 million by 2028, up from USD 65.15 million in 2021, growing at a compound annual growth rate (CAGR) of 7.0% from 2022 to 2028.

What Is Blood Irradiation?

Blood Irradiation is a process in which blood is exposed to low levels of radiation — at least 25 Gy (2,500 cGy) — to deactivate T lymphocytes and inhibit the immune response, primarily to prevent the rare but often fatal graft-versus-host disease (GvHD). Clinical indications for this therapy include acute leukemia, lymphoma, solid tumors receiving intensive chemotherapy or radiation therapy, exchange transfusions, organ transplant recipients, and preterm infants.

Request Sample Pages of this Research Study-https://www.theinsightpartners.com/sample/TIPRE00003256

Key Growth Drivers:

The primary engine powering this market is the rising global burden of both communicable and noncommunicable diseases. Cardiovascular disorders remain the leading cause of death worldwide, with approximately 17.9 million deaths reported annually, according to the World Health Organization. The rising prevalence of communicable diseases such as Hepatitis, HIV, and AIDS is also fueling demand — WHO reported that 325 million people were infected with the hepatitis B virus in 2020, with 900,000 deaths each year from that infection alone. An aging global population is another significant contributor. The population of people aged 60 and above was 1 billion in 2019 and is expected to grow to 1.4 billion by 2030 and 2.1 billion by 2050 — a demographic particularly vulnerable to conditions requiring blood transfusions and irradiation therapy. Additionally, bloodstream infections are a major cause of illness and death globally, with approximately 28,000 such infections occurring worldwide annually, according to the National Library of Medicine.

Top Key Players:

• Typenex Medical, LLC
• Hitachi Medical Systems
• Rad Source Technologies
• Gilardoni S.p.A.
• Gamma-Service Medical GmbH
• Actemium
• Best Theratronics L

Interested in Purchasing this Report? Click here-https://www.theinsightpartners.com/buy/TIPRE00003256

Market Segmentation:

The report segments the blood irradiation market by type, indication, and end user. By type, the market is divided into intravenous laser blood irradiation, transcutaneous laser blood irradiation, and extracorporeal blood irradiation. Intravenous laser blood irradiation held the largest market share in 2021, while the extracorporeal segment is expected to record the highest CAGR of 7.8% during the forecast period. By indication, the acute leukemia segment dominated the market, accounting for US$ 26.93 million in revenue in 2021. However, the lymphoma segment is expected to register the fastest growth, at a CAGR of 8.8%, through the forecast period. Among end users — which include hospitals, blood banks, diagnostics clinics, and research institutes — hospitals held the largest share in 2021, while blood banks are estimated to register the highest CAGR of 7.7% during the forecast period.

Regional Outlook:

North America, led by the United States, holds the largest regional share in the blood irradiation market, driven by rising R&D activities along with a surge in autoimmune disorders and organ transplants. Asia-Pacific is expected to record the fastest regional growth, fueled by the rising incidence of communicable and noncommunicable diseases across its large population.

Competitive Landscape:

Key players operating in the global blood irradiation market include Typenex Medical LLC, Hitachi Medical Systems, Rad Source Technologies, Gilardoni S.p.A., Gamma-Service Medical GmbH, Actemium, and Best Theratronics Ltd. Companies are focusing on product innovation to stay competitive. In June 2021, for example, Rad Source Technologies unveiled its redesigned RS 3400 Blood Irradiator at MEDLAB Middle East 2021, designed to replace self-shielded gamma irradiators.

Growth Challenges: Despite the optimistic outlook, the market faces headwinds. The high cost of blood irradiation procedures remains a significant restraint on overall market growth. Addressing affordability and accessibility will be key challenges for industry stakeholders in the years ahead. Overall, the blood irradiation market represents a niche but growing segment of the life sciences industry, underpinned by escalating disease burdens, advancing medical technologies, and expanding healthcare infrastructure across emerging economies.

Trending Related Reports:

•  Blood Collection Tubes Market Key Players, Opportunities, and Forecast by 2031
•  Blood Disorder Therapeutics Market Developments, Trends, and Forecast by 2031
•  Blood Lancet Market Growth, Trends, and Forecast by 2031
•  Blood Platelet Market Overview, Growth, and Research Report (2021-2031)

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.

Contact Us:

• If you have any queries about this report or if you would like further information, please get in touch with us:
• Contact Person: Ankit Mathur
• E-mail: ankit.mathur@theinsightpartners.com
• Phone: +1-646-491-9876
• Also Available in : Korean|German|Japanese|French|Chinese|Italian|Spanish